This result was consistent with that of a recent study, which showed that CD44 expression was required for collective motility and metastatic progression initiated by loss of Rb function in breast cancer.52 This suggested that cross-talks between Rb and CD44 pathways are required for BMP-2-dependent EMT and development of BCSCs. The gene discussed is BMP2; the disease is breast carcinoma.